Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 0.12%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Zhejiang Huakang Pharmaceutical Co (SHSE:605077) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Zhejiang Huakang Pharmaceutical Co 3-Year ROIIC % Related Terms
Zhejiang Huakang Pharmaceutical Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Huakang Pharmaceutical Co 3-Year ROIIC % Chart
For the Chemicals subindustry, Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Huakang Pharmaceutical Co 3-Year ROIIC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Zhejiang Huakang Pharmaceutical Co (SHSE:605077) has a 3-Year ROIIC % of 0.12 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Zhejiang Huakang Pharmaceutical Co and its competitors. This is 94% below median its historical median of 2.08. Over the past decade, Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC % has ranged from 0.12 to 257.60. According to the industry distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #762 out of 1530 companies in the Chemicals industry, placing it in the top 49.8%.
Is Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC % too high?
Zhejiang Huakang Pharmaceutical Co's current 3-Year ROIIC % of 0.12 is 94% below median its 10-year median of 2.08. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 257.60. The Chemicals industry median 3-Year ROIIC % is 0.03. Zhejiang Huakang Pharmaceutical Co's value of 0.12 is 380% above this industry median. Based on the distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #762 out of 1530 companies in the Chemicals industry, which is above the industry midpoint. Overall, Zhejiang Huakang Pharmaceutical Co has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Huakang Pharmaceutical Co's 3-Year ROIIC % compare to DOW?
According to the Chemicals industry distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #762 out of 1530 companies for 3-Year ROIIC %. This puts Zhejiang Huakang Pharmaceutical Co in the upper half of its industry. The industry median 3-Year ROIIC % is 0.03. Zhejiang Huakang Pharmaceutical Co's value of 0.12 is 380% above this benchmark. Historically, Zhejiang Huakang Pharmaceutical Co's own 3-Year ROIIC % has ranged from 0.12 to 257.60 over the past decade. While the company's 10-year median is 2.08 vs. the industry median of 0.03, Zhejiang Huakang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Chemicals company?
The median 3-Year ROIIC % among Chemicals companies is 0.03, based on 1,530 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Huakang Pharmaceutical Co's current 3-Year ROIIC % of 0.12 is 380% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Zhejiang Huakang Pharmaceutical Co and its competitors. For the Chemicals industry, the median 3-Year ROIIC % is 0.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Huakang Pharmaceutical Co's current 3-Year ROIIC % is 0.12, which is 94% below median its own 10-year median of 2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Huakang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Huakang Pharmaceutical Co (SHSE:605077) is currently considered Possible Value Trap. The stock's GF Value™ is ¥30.08, compared to a current price of ¥11.15 — trading 62.9% below its estimated fair value. The current 3-Year ROIIC % is 0.12, which is 94% below median its 10-year median of 2.08 and 380% above the Chemicals industry median of 0.03. Zhejiang Huakang Pharmaceutical Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Zhejiang Huakang Pharmaceutical Co (SHSE:605077), the current 3-Year ROIIC % is 0.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Huakang Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥11.15 is trading 62.9% below its estimated GF Value™ of ¥30.08.
GuruFocus considers Zhejiang Huakang Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for SHSE:605077:
3-Year ROIIC %: 0.12 (94% below median its 10-year median of 2.08)
GF Value™: ¥30.08 vs. price of ¥11.15 (62.9% below fair value)
Industry Position: 380% above the Chemicals median (#762 of 1530)
No single metric tells the full story. See the SHSE:605077 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.
69GF Score
Get the complete analysis for SHSE:605077
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605077 has been successfully added to your 
